GlassScriptPhysician profile
Peter Neil Brieloff
NPI 1134122138
$2,716.68
in general payments reported to CMS, 2019-2025
21 companies · $1,163 in 2025
The $1,163 reported for 2025 was more than what 83% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $238 · 2022: $524 · 2023: $555 · 2024: $237 · 2025: $1,163.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,455 · Consulting Fee: $500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,455.07 |
| Consulting Fee | $500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $872.88 | 2024-2025 | Intellis Adaptivestim, Inceptiv, Vanta Adaptivestim |
| Nevro Corp. | $352.08 | 2022-2023 | Senza |
| Amgen INC. | $195.68 | 2024-2025 | Krystexxa |
| Bioventus LLC | $178.08 | 2022-2025 | Xcell, Exogen Ultrasound Bone Healing System |
| Abbott Laboratories | $172.85 | 2023-2025 | Supera, Proclaim, Armada |
| Depuy Synthes Sales INC. | $167.60 | 2025 | Attune, Orthovisc, Monovisc |
| Melinta Therapeutics, LLC | $140.17 | 2019-2022 | |
| Triad Life Sciences INC. | $112.04 | 2022 | |
| Embody, INC. | $88.55 | 2022 | |
| Musculoskeletal Transplant Foundation INC. | $78.11 | 2019 | |
| Horizon Therapeutics Plc | $75.14 | 2022-2023 | Krystexxa |
| Stryker Corporation | $53.72 | 2023 | Ortholoc 2 Lapifuse, Tissuemend, Omega |
| Orthofix Medical, INC. | $41.93 | 2025 | Physio-Stim |
| Sebela Pharmaceuticals INC. | $40.46 | 2023 | Naftin, Pramosone |
| Smith+Nephew, INC. | $30.91 | 2019-2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $27.08 | 2022-2023 | Nuzyra |
| Heron Therapeutics, INC. | $19.26 | 2022 | |
| Janssen Pharmaceuticals, INC | $18.77 | 2019 | |
| Electronic Waveform Lab, INC. | $18.11 | 2025 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $18.10 | 2022 | |
| Curonix LLC | $15.16 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Brieloff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.